Senti Biosciences Holdings (SNTI) Earnings Date & Reports

Senti Biosciences Holdings Inc, formerly known as Senti Biosciences Inc, is a clinical-stage biotechnology company developing cell and gene therapies using its gene circuit platform for patients with incurable diseases... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

SNTI is expected to report earnings to rise 121.43% to -31 cents per share on August 18

Senti Biosciences Holdings SNTI Stock Earnings Reports

Q2'26

Est.

$-0.31

Q1'26

Beat

by $0.28

Q4'25

Missed

by $0.12

Q3'25

Missed

by $0.14

Q2'25

Missed

by $0.01

The last earnings report on May 14 showed earnings per share of -14 cents, beating the estimate of -41 cents. With 19.98K shares outstanding, the current market capitalization sits at 29.81M.

View a ticker or compare two or three

Compare

SNTI

Setup

Daily Signal:

Description

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

Last 5 trading days

View AI-Driven Trading for SNTI